On the evening of November 26, the Red Star Awards – Outstanding Young Entrepreneurs of Vietnam 2025 Ceremony took place in Hanoi. Mr. Ha Linh – CEO of Nam Ha Pharmaceutical Joint Stock Company – was honored to be listed among the TOP 100 Outstanding Young Entrepreneurs of Vietnam this year.

The ceremony was attended by Mr. Do Van Chien, Politburo member and Standing Vice Chairman of the National Assembly; Mr. Ho Quoc Dung, Member of the Party Central Committee and Deputy Prime Minister; along with leaders of central ministries and agencies, and nearly 1,500 delegates representing the national business community.

The award follows a rigorous three-round evaluation process: Preliminary Screening, On-site Appraisal at candidate enterprises, and Final Selection. The Final Council worked objectively and meticulously to select the TOP 100 Outstanding Young Entrepreneurs of Vietnam 2025. Mr. Ha Linh – CEO of Nam Ha Pharmaceutical – is among those honored. This prestigious recognition celebrates his significant contributions during nearly five years of leadership at Nam Ha Pharma.

Mr. Ha Linh – CEO of Nam Ha Pharma – receives the Top 100 Outstanding Young Entrepreneurs of Vietnam 2025 Award

He shared: “Being honored at the Red Star Awards – Outstanding Young Entrepreneurs of Vietnam 2025 is a great pride, and also a responsibility that encourages Nam Ha Pharma to continue innovating, integrating globally, and pursuing sustainable development”.

As CEO of Nam Ha Pharmaceutical Joint Stock Company, Mr. Ha Linh has prioritized building strategic direction, vision, and operational plans – leading Nam Ha Pharma into a new era of comprehensive and transformative growth.

The NamHa Pharma’s CEO proudly receives the award

With the vision of “Developing a complete and sustainable Medical – Pharmaceutical ecosystem”, he has implemented the strategy “Innovation – Integration – Sustainable Development”, aiming to position Nam Ha Pharma as a leading healthcare enterprise in Vietnam and gradually expand its global footprint.

• Comprehensive innovation in products and technology:

Expanding its portfolio from modern pharmaceuticals, traditional herbal medicines, health supplements, and cosmetics to medical equipment.

Upgrading and operating two modern WHO-GMP-standard factories across nearly 40,000 sqm; digitizing production workflows, automating quality control, and implementing an integrated enterprise management system.

This marks a shift in approach, as Mr. Ha Linh emphasizes technological innovation and automation rather than only expanding scale.

• Global integration and expansion of the value chain:

Establishing strategic partnerships with major international players such as Yangtze River Pharmaceutical Group and Kexing Biopharm (China), enabling technology transfer and the development of an FDA-standard manufacturing plant in Vietnam.

Strengthening e-commerce, restructuring distribution across more than 10,000 pharmacies in 34 provinces, bringing Nam Ha Pharma closer to customers through modern and agile channels.

• People and corporate culture as the foundation:

Building a fair, transparent, cohesive, and inspiring workplace environment.

Implementing continuous training programs, developing high-quality human resources, and advancing people capabilities alongside business growth.

• Sustainable development and social responsibility:

Mr. Ha Linh guides Nam Ha Pharma toward becoming a socially responsible enterprise through medical missions, free medicine programs, blood donation drives, and investment in national herbal cultivation areas, while prioritizing green manufacturing and minimizing environmental impact.

With a forward-thinking, creative, and decisive approach, Mr. Ha Linh has not only reshaped Nam Ha Pharma’s product, technology, and distribution strategies, but also built a holistic Medical–Pharmaceutical ecosystem that balances quality, business performance, human value, customer trust, and social impact—toward international influence.

The award honors young Vietnamese entrepreneurs

The title of TOP 100 Outstanding Young Entrepreneurs of Vietnam 2025 is not only a well-deserved recognition of Mr. Ha Linh’s extraordinary efforts and achievements, but also affirms the capability, leadership, and vision of Vietnam’s new generation of leaders in an era of integration and digital transformation.

Mr. Ha Linh’s recognition at the Red Star Awards once again reinforces his strategic vision and exceptional leadership, contributing to strengthening Nam Ha Pharma’s position in Vietnam’s pharmaceutical industry.

Looking ahead, CEO Ha Linh and Nam Ha Pharma aim to expand domestic and global influence, foster innovation, and deliver high-quality, safe products for the community. With strong core values, a competent workforce, and an unwavering sense of social responsibility, Nam Ha Pharma is committed to sustainable development and to improving the health of the Vietnamese people.